InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Doyle William F, Président Exécutif. Insider active across 2 companies, notably NovoCure Ltd. Aggregated, 10 disclosures have been logged. Split: 2 buys · 3 sells. Total volume traded: €794k. History available since 2 August 2021. The latest transaction was disclosed on 3 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Doyle William F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
200,000 shares0Ordinary SharesSEC:0001194459-26-000001:0
18,169 shares0Common StockSEC:0001415889-24-028153:0
15,000 shares@ US$16.9851.2% of flowCommon StockSEC:0001415889-24-014279:0
Canonical exit: 19 Aug 2024 (T+90)
15,000 shares@ US$16.3048.8% of flowCommon StockSEC:0001415889-24-007635:0
Canonical exit: 6 Jun 2024 (T+90)
20,374 shares0Common StockSEC:0001415889-23-015780:0
18,649 shares0Common StockSEC:0001415889-22-011980:0
837 shares@ US$69.65912.4% of flowOrdinary SharesSEC:0001645113-22-000071:0
2,385 shares@ US$70.1045.7% of flowOrdinary SharesSEC:0001645113-22-000024:0
7,307 shares0Common StockSEC:0001179110-21-010527:0
995 shares@ US$149.37837.2% of flowOrdinary SharesSEC:0001645113-21-000096:0
10 of 10 declarations
About Doyle William F
DOYLE WILLIAM F is Président Exécutif. He is also a Director at Elanco Animal Health Inc and Executive Chairman at NovoCure Ltd. His 10 filings cover the most recent filings we hold, from 2021-08-04 to 2026-03-05, with EUR 457919 of purchases and EUR 336451 of sales, and the modal transaction nature is Attribution.
